Concepedia
Statistics
Publications
6
Citations
157
H-Index
Active since
2000
Affiliations
Novartis (Switzerland)(Current)
Tris Pharma (United States)
James Vivelo is an author at Novartis (Switzerland) specializing in drug discovery, pharmacy, and medicinal chemistry.
Publications per year
2000–2010
Selective deprotection of alkyl t-butyldimethylsilyl ethers in the presence of aryl t-butyldimethylsilyl ethers with bismuth bromide
Joginder S. Bajwa, James Vivelo, Joel Slade et al. · Tetrahedron Letters · 2000 · 54 citations
Natural Sciences, Chemistry, Organic Chemistry +7
A Concise Synthesis of a Novel Insulin-Like Growth Factor I Receptor (IGF-IR) Inhibitor
Joel Slade, Joginder S. Bajwa, Hui Liu et al. · Organic Process Research & Development · 2007 · 38 citations
Pharmacy, Chemistry, Medicinal Chemistry +11
A Practical Enantioselective Synthesis of a Novel Peptide Deformylase Inhibitor
Joel Slade, David Parker, Michael Girgis et al. · Organic Process Research & Development · 2005 · 24 citations
Pharmacy, Biochemistry, Medicinal Chemistry +13
Process Research and Development of a MTP Inhibitor: Another Case of Disappearing Polymorphs upon Scale-up
Mahavir Prashad, Paul Sutton, Raeann Wu et al. · Organic Process Research & Development · 2010 · 16 citations
Life Sciences, Biochemistry, Pharmacology +13
An Expedient Synthesis of 6α-Fluoroursodeoxycholic Acid
Kurt Königsberger, Guang‐Pei Chen, James Vivelo et al. · Organic Process Research & Development · 2002 · 15 citations
Pharmacy, Medicinal Chemistry, Pharmacology +6
1–5 of 6